alendronate has been researched along with alprostadil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Douguet, D | 1 |
| Gao, F; Guo, W; Wang, W; Zhang, N | 1 |
4 other study(ies) available for alendronate and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs.
Topics: | 2018 |
Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up.
Topics: Adult; Alendronate; Alprostadil; Bone Density Conservation Agents; Drug Therapy, Combination; Enoxaparin; Female; Femur Head Necrosis; Fibrinolytic Agents; Follow-Up Studies; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Retrospective Studies; Severe Acute Respiratory Syndrome; Treatment Outcome | 2018 |